IBL-302, CAS [[1414455-21-2]]

Product Overview

• Article Name: IBL-302, CAS [[1414455-21-2]]
• Biozol Catalog Number: MCE-HY-157169
• Supplier Catalog Number: HY-157169
• Alternative Catalog Number: MCE-HY-157169-25MG,MCE-HY-157169-1MG,MCE-HY-157169-10MG,MCE-HY-157169-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: AMU302

Product Description

IBL-302 (AMU302) is an orally available dual-signaling inhibitor of PIM and PI3K/AKT/mTOR with activity against breast cancer and neuroblastoma. IBL-302 demonstrated in vivo efficacy in a nude mouse xenograft model, inhibiting trastuzumab (HY-P9907) resistance challenges. IBL-302 also enhances the effects of common cytotoxic chemotherapy drugs cisplatin (HY-17394), doxorubicin (HY-15142A), and etoposide (HY-13629)[1][2][3].

Product Properties

• Molecular Weight: 567.63
• Purity: 98.21
• CAS Number: [1414455-21-2]
• Formula: C25H18FN5O4S3
• Target: Akt,mTOR,PI3K,Pim

Application Notes

• Application Notes: MCE Product type: Reference compound1